Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2011, Vol. 31 Issue (03): 18-22    
研究报告     
可溶型三聚体血管生长抑制因子Kringle5的克隆,表达,纯化及活性研究
妙亮, 徐立华, 冀胥, 边六交
西北大学生命科学学院 西安 710069
Cloning, Expression, Purification and its Biological Activity Study of the Soluble Tripolymer Recombinant Angiogenesis Inhibitor Kringle 5
MIAO Liang, XU Li-hua, JI Xu, BIAN Liu-jiao
College of Life Sciences, Northwest University, Xi’an 710069, China
 全文: PDF(606 KB)   HTML
摘要:

血管生长抑制因子Kringle 5 是目前发现的抑制血管内皮细胞增殖和肿瘤生长的活性最强的纤溶酶原片段,特异性高而毒副作用小,在肿瘤的治疗方面具有潜在的巨大价值和广阔的应用前景。根据K5基因的序列设计PCR引物,通过PCR从已有的克隆载体扩增出人纤维蛋白溶酶原的K5部分基因,将K5基因克隆入原核表达载体pET15b,经序列测定,成功构建了pET15b-K5非融合表达载体。将重组载体导入大肠杆菌中IPTG诱导表达,SDS-PAGE分析目的蛋白主要以可溶形式存在于菌体中,破碎后上清通过阳离子交换层析,纯化获得纯度大于95%的目标蛋白,脱盐后对分子量测定推测形成了三聚体。通过鸡胚绒毛尿囊膜法证明蛋白产物对鸡胚绒毛尿囊膜血管增生有一定的抑制作用。

关键词: Kringle 5克隆分离纯化生物活性    
Abstract:

The Kringle 5 domain of plasminogen, which was previously shown to inhibit angiogenesis in vitro and vivo, is one of the most potent angiogenesis inhibitors described to date.The Kringle 5 gene was amplified from pET32a-K5 by PCR, and then was inserted into pET15b to construct a prokaryotic vector pET15b-k5.The target protein was highly expressed in E.coli BL21(DE3) and was mainly present in the precipitation observed by SDS-PAGE. The protein was purified by ion-exchange chromatography (SP Sepharose Fast-Flow) using the NaCl linear gradient strategy. The analysis results of SDS-PAGE showed that the purity of obtained Kringle 5 was about 98%. After desalting with size-exclusion chromatography, it was found that it inhibited the blood vessel growth of chick embryo chorioallantoic membrane effectively. This simple, effective method may be applied in the future in mass production of Kringle 5 and lay a solid base for detailed evaluation of bioactivities of Kringle 5.

Key words: Kringle 5    Cloning    Separation and purification    Biological activity
收稿日期: 2010-11-10 出版日期: 2011-04-01
ZTFLH:  Q789  
基金资助:

国家"重大新药创制"科技重大专项资助项目(2009ZX09103-696)

通讯作者: 边六交     E-mail: bianliujiao@sohu.com
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
妙亮
边六交

引用本文:

妙亮, 徐立华, 冀胥, 边六交. 可溶型三聚体血管生长抑制因子Kringle5的克隆,表达,纯化及活性研究[J]. 中国生物工程杂志, 2011, 31(03): 18-22.

MIAO Liang, XU Li-hua, JI Xu, BIAN Liu-jiao. Cloning, Expression, Purification and its Biological Activity Study of the Soluble Tripolymer Recombinant Angiogenesis Inhibitor Kringle 5. China Biotechnology, 2011, 31(03): 18-22.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/        https://manu60.magtech.com.cn/biotech/CN/Y2011/V31/I03/18

[1] Cao Y, Tumor angiogenesis and therapy. Biomedicine & Pharmacotherapy, 2005, 59(2): 340-343.
[2] Ji W R,Barrientos L G,Llinas M,et al. Selective inhibition by Kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. Biochem Biophys Res Commun, 1998, 247(2): 414-419.
[3] Ji W R,Castelkino F J,Chang Y, et al. Characterization of Kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. Faseb, 1998, 12(15): 1731-1738.
[4] Nguyen T M,Subramanian I V,Kelekar A,et al. Kringle 5 of human plasminogen,an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells. Blood, 2007, 109(11): 4793-4802.
[5] 边六交, 党红艳, 杨晓燕. 原核表达融合型血管生成抑制剂Kringle 5发酵条件的优化和初步纯化. 高校化学工程学报, 2006, 20(5): 775-780. Bian L J,Dang H Y,Yang X Y, Journal of Chemical Engineering of Chinese Universities, 2006, 20(5): 775-780.
[6] 周涟, 罗进贤, 张添元. 血管生成抑制素基因工程大肠杆菌的高密度发酵研究. 微生物学报, 2003, 43(2): 228-235. Zhou L,Luo J X,Zhang T Y. Acta Microbiologica Sinica, 2003, 43(2): 228-235.
[7] 贾信贵, 边六交. 两步柱色谱法分离纯化重组肿瘤血管生长抑制因子Kringle 5. 色谱, 2007, 25(3): 344-347. Jia X G,Bian L J. Chinese Journal of Chromatography, 2007, 25(3): 344-347.
[8] 汪家政. 蛋白质技术手册. 北京: 科学出版社, 2000.23-24. Wang J Z. Protein Technical Manual. Beijing:Science Press, 2000.23-24.
[9] 陈浩, 陈于红, 张菁,等. 人纤溶酶原Kringle 5基因的克隆、表达及产物纯化和性质鉴定. 南京大学学报(自然科学版), 2001, 37(2): 218-222. Chen H,Chen Y H,Zhang J, et al.Journal of Nanjing University(Natural Sciences), 2001, 37(2): 218-222.
[10] 梁欣. 复杂蛋白质样品中目标组分柱层析分离纯化策略研究. 西安:西北大学,化工学院, 2009. Liang X. Isolation and purification strategy of target protein in binary-and ternary-protein mixture on column chromatography. Xi’an: Northwest University, College of Chemistry & Chemical Engineering, 2009.
[11] 吴鹏, 杨晓燕, 边六交. 一种从蛇毒中纯化神经生长因子的新工艺.色谱, 2004, 22(1): 1-4. Wu P,Yang X Y,Bian L J. Chinese Journal of Chromatography, 2004,22(1):1-4.
[12] 王亚妮,刘先宁. 重组人色素上皮细胞衍生因子融合蛋白的制备及其抑制新生血管活性的研究. 中国生物工程杂志, 2008, 28 (12): 12-17. Wang Y N, Liu X N. China Biotechnology, 2008, 28 (12): 12-17.
[13] Susan J, Janet M T. Principles of protein-protein interactions. Proc Natl Acad Sci, 1996, 93(1):13-20.
[14] 井明艳,孙建义. 蛋白质的折叠调控与包涵体的形成. 浙江大学学报(农业与生命科学版), 2004, 30 (6): 690-696. Jing M Y, Sun J Y. Journal of Zhejiang University(Agric. & Life Sci.), 2004, 30 (6): 690-696.
[15] Kazumasa S, MotoHisa O, Yuji G. Salt-dependent monomer-dimer equilibrium of bovine β-lactoglobulin at pH3. Protein Science, 2001, 10(11):2325-2335.
[16] Thongngam M, Mcclements D J. Influence of pH, ionic strength, and temperature on self-association and interactions of sodium dodecyl sulfate in the absence and presence of chitosan. Langmuir, 2005, 21(1):79-86.
[17] Welch W J. Role of quality control pathways in human diseases involving protein misfolding. Seminars in Cell and Developmental Biology, 2004, 15 (1): 31-38.

[1] 陈修月,周文锋,何庆,苏冰,邹亚文. 噬菌体Qβ病毒样颗粒的制备、纯化及鉴定[J]. 中国生物工程杂志, 2021, 41(7): 42-49.
[2] 张虎,刘镇洲,陈家敏,高保燕,张成武. 利用海洋硅藻生产生物活性物质研究进展*[J]. 中国生物工程杂志, 2021, 41(4): 81-90.
[3] 赵妍淑,张金华,宋浩. 工程原核生物和酵母菌中生产单克隆抗体和抗体片段研究进展 *[J]. 中国生物工程杂志, 2020, 40(8): 74-83.
[4] 贾晓,邱瑾,舒娟,李华,习书斌,曾溢滔,曾凡一. 血清孕酮水平检测在克隆胚胎移植受体牛的筛选及妊娠诊断中的应用 *[J]. 中国生物工程杂志, 2020, 40(7): 1-8.
[5] 王猛,宋慧茹,程雨洁,王毅,杨波,胡征. 以核糖体蛋白L7/L12为分子标志物精准检测肺炎链球菌的研究 *[J]. 中国生物工程杂志, 2020, 40(4): 34-41.
[6] 陈秋利,杨丽超,李辉,温莎,李刚,何敏. 人Nek2蛋白原核表达纯化及其多克隆抗体制备 *[J]. 中国生物工程杂志, 2020, 40(3): 31-37.
[7] 孔建涛,庄英萍,郭美锦. 基于DOE设计和氨基酸补加策略提高CHO细胞表达抗CD20单克隆抗体*[J]. 中国生物工程杂志, 2020, 40(12): 41-48.
[8] 陈春琳,秦松,宋宛霖,刘志丹,刘正一. 褐藻寡糖生物法制备研究进展 *[J]. 中国生物工程杂志, 2020, 40(10): 85-95.
[9] 吝建华,韩君,徐寒梅. PD-1/PD-L1免疫检查点抗体药物制剂稳定性开发[J]. 中国生物工程杂志, 2020, 40(10): 35-42.
[10] 袁晓英,王亚哲,石韦华,常艳,郝乐,贺玲玲,石红霞,黄晓军,刘艳荣. 流式检测PNH克隆的方法学探讨及临床筛检和意义 *[J]. 中国生物工程杂志, 2019, 39(9): 33-40.
[11] 江一帆,贾宇,王龙,王志明. 细胞培养过程对单克隆抗体糖基化修饰的影响和调控[J]. 中国生物工程杂志, 2019, 39(8): 95-103.
[12] 石俊松,罗绿花,周荣,麦然标,纪红美,余婉娴,吴珍芳,蔡更元. 延迟激活对猪克隆胚胎体外、体内发育效率的影响 *[J]. 中国生物工程杂志, 2019, 39(4): 16-23.
[13] 江一帆,董静,魏敬双. 工程细胞单克隆筛选及单克隆源性验证 *[J]. 中国生物工程杂志, 2019, 39(4): 101-105.
[14] 高倩,江洪,叶茂,郭文娟. 全球单克隆抗体药物研发现状及发展趋势 *[J]. 中国生物工程杂志, 2019, 39(3): 111-119.
[15] 刘国芳,刘晓志,高健,王志明. 宿主细胞残留蛋白质对单克隆抗体药物质量影响及其质量控制 *[J]. 中国生物工程杂志, 2019, 39(10): 105-110.